REGULATORY REQUIREMENTS OF ‘SIMILAR BIOLOGICS’ FOR MARKETING AUTHORIZATION IN INDIA

Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 1

Abstract

Present article signifies the exigency for regulation and regulatory bodies involved in development of biosimilars. The principle for development of biosimilars included opting adequate reference product, manufacturing process optimization, quality control procedure, preclinical and clinical studies. India’s first guidelines were enforced in 2012, with amendments in 2016. Thus, we elaborated the amended guidelines for development of biosimilars.

Authors and Affiliations

Sharmila Reddy V, Mounica N. V. N. , Anusha S, Evangeline L, Nagabhushanam M. V. , Nagarjunareddy D

Keywords

Related Articles

A SNAP-SHOT OF FIRST-LINE ART TREATMENT FAILURE CASES FROM MPUMALANGA PROVINCE ON THE DECENTRALISED PHARMACOVIGILANCE PROGRAMME DATABASE

The increase in ART use comes with the inevitable increase in cases of ART treatment failure, especially that patients are living longer on ART. The main objective of this short study was to conduct an interim review of...

PYRAZOLINE SYNTHESIS THROUGH A CHALCONE INTERMEDIATE

Pyrazoline derivatives, being used as potential medicinal agents, possess many important pharmacological activities and therefore they are useful materials in drug research. A series of these derivatives HT- 1 to HT- 6 c...

FORMULATION AND DEVELOPMENT OF KETOPROFEN BILAYER TABLETS

Aim of present research work was formulation and development of bilayer tablets of Ketoprofen to reduce the side effects of Ketoprofen and to improve the therapeutic benefits and patients’ compliance to treatment. Bi-lay...

FORMULATION AND IN-VITRO EVALUATION OF HOLLOW MICROSPHERES OF GLIPIZIDE

Present work involves attempts to improve floating time of glipizide by formulation of hollow microspheres incorporating Glyceryl Monostearate and acryflow. The floating microspheres were evaluated for percentage yield,...

OCULAR DRUG DELIVERY: RECENT UPDATES

Ophthalmic route is one of the most promising delivery systems for the treatment of eye ailments. Delivery of medicaments to anterior segment of the eye is an easy task. However with the rising number of posterior segmen...

Download PDF file
  • EP ID EP326661
  • DOI 10.22270/ijdra.v5i1.193
  • Views 151
  • Downloads 0

How To Cite

Sharmila Reddy V, Mounica N. V. N. , Anusha S, Evangeline L, Nagabhushanam M. V. , Nagarjunareddy D (2017). REGULATORY REQUIREMENTS OF ‘SIMILAR BIOLOGICS’ FOR MARKETING AUTHORIZATION IN INDIA. International Journal of Drug Regulatory Affairs, 5(1), 20-24. https://europub.co.uk./articles/-A-326661